tradingkey.logo

BRIEF-Tempest Granted Fast Track Designation From The U.S. Food And Drug Administration For Amezalpat

ReutersFeb 10, 2025 1:04 PM

- Tempest Therapeutics TPST.O:

  • TEMPEST GRANTED FAST TRACK DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION FOR AMEZALPAT TO TREAT PATIENTS WITH HEPATOCELLULAR CARCINOMA

Source text: ID:nGNX5h7lh8

Further company coverage: TPST.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI